HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
COVID-19 Impact on World-Wide Pharma Companies
During C0VID-19, industry growth has slow-down, delay in approvals, and self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical crisis could be anticipated as long-term impacts of COVID-19 pandemic on the pharmaceutical sector in both global and local levels.
Committee Members
Saad Tayyab
UCSI University, Malaysia
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Marino Nebuloni
University of Insubria, Italy PDDS 2025 Speakers
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Marino Nebuloni
University of Insubria, Italy
Saad Tayyab
UCSI University, MalaysiaSubmit your abstract Today
Title : Medical liver Biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/Tadalafil Combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia